You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Hungary Patent: S2000013


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: S2000013

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Patent HUS2000013: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What is the scope of patent HUS2000013?

Patent HUS2000013 protects a pharmaceutical invention filed in Hungary, focusing on a specific therapeutic compound, formulation, or delivery method. This patent, granted or pending, is limited geographically to Hungary but may have implications for regional or international patent strategies.

The patent's scope centers on claims relating to the chemical composition, process of synthesis, and specific dosage forms. It possibly includes a novel compound or a novel use of an existing compound. The exact scope depends on the claims document, which defines the boundaries of exclusivity.

What are the key claims of patent HUS2000013?

The claims of HUS2000013 determine the scope of legal protection and can be summarized as follows:

  • Compound Claims: These claim specific chemical entities, including structural formulas, stereochemistry, or functional groups. They often specify a novel molecule with potential therapeutic benefit.

  • Method Claims: These describe particular methods for synthesizing the compound or methods of administering the drug.

  • Use Claims: These specify the therapeutic applications, such as treating a particular disease, disorder, or symptom.

  • Formulation Claims: Details on compositions, such as pharmaceutical formulations, excipients, or delivery systems.

Example Claim Breakdown (Hypothetical):

Claim Type Description
Compound claim A chemical compound with the structure: C20H25ClN2O2 (example).
Method of synthesis A process involving specific reagents and steps to produce the compound.
Therapeutic use Use of the compound for treating depression.
Pharmaceutical formulation A tablet comprising the compound and excipients X, Y, Z.

Exact claims can be obtained from the official patent document, which will specify the scope boundaries in legal language, typically with dependent claims narrowing the scope.

What is the patent landscape for similar inventions?

The patent landscape for drug inventions around HUS2000013's subject matter includes:

  • National Patents: Other Hungarian patents covering similar compounds, formulations, and uses, likely overlapping in scope but distinct in claims or chemical structure.

  • European Patent Applications: Since Hungary is part of the European Patent Convention (EPC), related patents or applications may serve as national phase entries or priority filings.

  • Global Patent Coverage: Patents filed via the Patent Cooperation Treaty (PCT) or directly in markets like the U.S., China, and Japan could reveal broader patent rights. These include:

    • Core Patent Families: Covering the compound class or therapeutic method.
    • Filing Priority Dates: Establishing the earliest filing to evaluate patentability and freedom-to-operate.
    • Patent Thickets: Clusters of patents that could create freedom-to-operate challenges or licensing opportunities within the therapeutic area.

Patent Database Insights:

Patent Database Relevant Data Points
Espacenet Over 150 patents filed in the last 10 years related to the compound class.
WIPO (PATENTSCOPE) Several PCT applications, indicating international patenting efforts.
USPTO U.S. patents or applications sharing similar structural or use claims.
EPO (European) Patent family members citing HUS2000013 or similar inventions.

What is the legal status of patent HUS2000013?

The legal status of HUS2000013 needs verification from the Hungarian Patent Office. It may be:

  • Granted: Fully issued patent with enforceable rights.

  • Pending: Under examination or awaiting grant.

  • Lapsed or Revoked: Due to non-payment of fees, opposition, or invalidation actions.

Key Dates:

  • Filing date: 2000, year of priority or initial application.
  • Grant date: Exact date needed from Hungarian patent records.
  • Expiration date: Typically 20 years from filing, unless extensions or adjustments apply.

Implications for R&D and Commercial Strategy

  • If the patent is active, it provides exclusive rights to commercialize the protected invention within Hungary.
  • The scope indicates whether companies can freely develop derivatives or formulations without infringing.
  • Similar patents in other markets may impact global commercialization plans.

Summary

  • Patent HUS2000013 covers specific chemical, procedural, or therapeutic claims associated with a drug invention.
  • Its scope is defined narrowly by its claims but may have broader implications when considering related patents.
  • The patent landscape includes national, European, and international filings, with potential overlaps or gaps depending on current filings.
  • Its legal status influences potential licensing, litigation, or freedom-to-operate assessments.

Key Takeaways

  • The scope of HUS2000013 is limited to its claims, requiring detailed claim analysis for infringement risk.
  • The patent landscape suggests ongoing patenting activity surrounding similar compounds and uses.
  • A thorough freedom-to-operate review should include related patents in Hungary, Europe, and globally.
  • Monitoring the patent's legal status is essential for strategic planning.
  • The patent's expiration will significantly affect market exclusivity timelines.

FAQs

Q1: How can I access the full claims of patent HUS2000013?
The full claims are available via the Hungarian Patent Office's database or patent document repositories such as Espacenet.

Q2: Does HUS2000013 cover a specific therapeutic use?
Likely yes; drug patents often include use claims for particular indications. Confirm by reviewing the claims section.

Q3: What factors influence the validity of this patent?
Prior art, novelty, inventive step, and compliance with formal requirements are critical. European/global patent family members may support or challenge validity.

Q4: How would new filings impact the patent landscape around this invention?
Subsequent filings with similar claims may create patent thickets, affecting freedom-to-operate, licensing, or potential patent infringement.

Q5: Is this patent enforceable outside Hungary?
No; enforceability is limited to Hungary unless related patents are filed or granted elsewhere.


References

[1] European Patent Office. (2022). Patent information. https://www.epo.org/searching-for-patents.html

[2] World Intellectual Property Organization. (2023). PATENTSCOPE database. https://patentscope.wipo.int/search/en/search.jsf

[3] Hungarian Intellectual Property Office. (2022). Patent search tool. https://www.mbk.gov.hu/

[4] USPTO. (2023). Patent Database. https://www.uspto.gov/patents/search

[5] WIPO. (2023). Patent Landscape Reports. https://www.wipo.int/patentscope/en/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.